CCO 2021 Global Conference Coverage: Gynecologic Cancer Updates

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Cancer Conversations™ PARP Inhibitors in Ovarian Cancer

Content Format:

Case Challenge

Credit Type:

AMA

Credits:

0.75
ExpressPointsCancer Conversations™: PARP Inhibitors in Ovarian Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Cancer Conversations™: PARP Inhibitors in Ovarian Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Current Challenges in the Management of Endometrial and Ovarian Cancers

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Insight on Key Data From SGO 2021 Informing Treatment for Endometrial and Ovarian Cancer

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Precision Medicine in Ovarian Cancer: Understanding the Evolving Role of PARP Inhibitors

Content Format:

Multimedia

Credit Type:

--

Credits:

--
My Perspective on the Recent Approval of Niraparib as First-line Maintenance Therapy in Ovarian Cancer and the Clinical Implications

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
PARP Inhibitors in Recurrent Ovarian Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Treatment Options From 5 Experts for Advanced Ovarian Cancer: An Online Tool for Patients

Content Format:

Tool

Credit Type:

--

Credits:

--
How I Am Using PARP Inhibitors in the Care of Patients With Ovarian Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--